Since joining Amadeus Capital, Ana has advocated for multiple investments in the Life Sciences and SynBio sectors, including Nuclera, Oxford Nanopore, Ori Biotech and Constructive Bio. Ana has a keen interest in the business models and market dynamics in these sectors, and works closely with the companies to design the best commercial and growth strategies. Prior to joining Amadeus, Ana worked in a top-tier management consulting firm in London, where she conducted due diligence and strategy projects for a variety of private equity and corporate clients. Ana is Spanish and holds a PhD in Biophysics from the University of Cambridge and an MSc in Chemistry from Universidad Complutense de Madrid, Spain. She has lived and worked both in Germany and the US, and speaks Spanish and English.